GH - Healthcare rallies as Presidential vote count continues

The vote count to decide the next U.S. commander-in-chief is ongoing but healthcare investors do not appear concerned about who will eventually prevail since most industries are up in lockstep with the broad market rally.Big Biopharma leaders: Eli Lilly ([[LLY]] +14.6%), AbbVie ([[ABBV]] +9.4%).Biotech: Biogen (on expected positive Ad Com vote on Alzheimer's drug) ([[BIIB]] +40.9%), gene editors Editas Medicine ([[EDIT]] +8.8%), Intellia Therapeutics ([[NTLA]] +9.3%), CRISPR Therapeutics ([[CRSP]] +10.6%).Health insurers: UnitedHealth Group ([[UNH]] +10.7%), Cigna ([[CI]] +14.2%), Anthem ([[ANTM]] +12.6%).Drug wholesalers: AmerisourceBergen ([[ABC]] +4.2%), Cardinal Health ([[CAH]] +3.9%).Devices: Edwards Lifesciences ([[EW]] +3.9%), Abbott ([[ABT]] +3.3%).Gene therapy developers: Ultragenyx Pharmaceuticals ([[RARE]] +10.7%), Sarepta Therapeutics ([[SRPT]] +8.3%).Liquid biopsy: Precipio ([[PRPO]] +7.0%), Guardant Health ([[GH]] +5.9%).

For further details see:

Healthcare rallies as Presidential vote count continues